Patents
US 12414979 B2: Compositions and methods for treating Sjogren's syndrome
- Granted
- 2025-09-16
- Filed
- 2021-11-03 application 17517886
- Type
- Utility · 10 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention provides compositions and methods for treating Sjogren's syndrome (SS), including primary or secondary SS, as well as methods for preventing clinical disease in patients at risk of developing clinical SS. In various embodiments, the invention relates to administering a regimen of larazotide (or derivative) and/or 4-APAA compounds or 5-ASA compounds (e.g., 5-ASA, 4-ASA, 4-Ac APAA, and 4-APAA) to a patient in need thereof.
Source: PVGPATDIS, file of 2026-04-10 (ipg250916.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Interlude Biopharma Co. 2 patents | US company or organization | Miami, FL | PVGPATDIS, file of 2026-04-10 | |
| Oklahoma Medical Research Foundation 57 patents | US company or organization | Oklahoma City, OK | OKLAHOMA MEDICAL RESEARCH FOUNDATION Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Jay P. MADAN | Raleigh, NC | 6 | PVGPATDIS, file of 2026-04-10 | |
| Kathy L. Sivils | Oklahoma City, OK | 1 | PVGPATDIS, file of 2026-04-10 | |
| Umesh Deshmukh | Oklahoma City, OK | 1 | PVGPATDIS, file of 2026-04-10 | |
| Balasingham Radhakrishnan | Raleigh, NC | 3 | PVGPATDIS, file of 2026-04-10 | |
| Kendyle Kennsengten | Raleigh, NC | 1 | PVGPATDIS, file of 2026-04-10 | |
| Harini Bagavant | Oklahoma City, OK | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K38/08 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P1/02 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2024-05-21 | Name change Change of name | EBRIS PHARMA CO. signed 2024-04-01 | INTERLUDE BIOPHARMA CO. MIAMI, FL | 67485/755 | ECORSEXC, file of 2026-09-25 |
| 2024-05-21 | Assignment Assignment of assignor's interest | 9 METERS BIOPHARMA, INC. signed 2024-01-08 | EBRIS PHARMA CO. MIAMI, FL | 67485/438 | ECORSEXC, file of 2026-09-25 |
| 2023-04-10 | Security interest Security interest Intellectual property security agreement | 9 METERS BIOPHARMA, INC. signed 2022-07-15 NAIA RARE DISEASES, LLC signed 2022-07-15 | HIGH TRAIL SPECIAL SITUATIONS LLC HOBOKEN, NJ | 63281/653 | PASDL, file of 2026-10-15 |
| 2023-01-25 | Name change Change of name | INNOVATE BIOPHARMACEUTICALS, INC. signed 2020-04-30 | 9 METERS BIOPHARMA, INC. RALEIGH, NC | 62493/13 | ECORSEXC, file of 2026-09-25 |
| 2023-01-25 | Assignment Assignment of assignor's interest | MADAN, JAY P. signed 2020-04-13 RADHAKRISHNAN, BALASINGHAM signed 2020-04-13 WOODARD, KENDYLE signed 2020-04-13 BAGAVANT, HARINI signed 2020-04-20 DESHMUKH, UMESH signed 2020-04-20 SIVILS, KATHY L. signed 2020-04-20 | INNOVATE BIOPHARMACEUTICALS, INC. RALEIGH, NC | 62480/265 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.